Literature DB >> 24190398

Comparison of clinical presentation and laboratory values at admission between PCR-confirmed influenza A H1N1 infection and influenza-like disease, South-East Austria.

M Hoenigl1, J Prattes, M Drescher, K Tovilo, K Seeber, H H Kessler, K Vander, M Palfner, M Meilinger, A Avian, T Valentin, I Zollner-Schwetz, V Strenger, R Krause, H Flick.   

Abstract

PURPOSE: Reliable and rapid diagnosis of influenza A H1N1 is essential to initiate the appropriate antiviral therapy and preventive measures. As PCR assays are time-consuming and rapid antigen tests have a limited sensitivity, official influenza case definitions are used in many clinical settings. These, however, are based exclusively on clinical criteria and have only a moderate potential to differentiate between influenza and other febrile diseases. Only limited data on the differences in clinical and laboratory parameters between influenza and non-influenza febrile diseases are available to date.
METHODS: This was a retrospective case-negative control series that was conducted in Styria, southeast Austria. We analyzed the differences in clinical presentation and laboratory admission parameters between patients with PCR-confirmed H1N1 influenza infection (n = 199) and those with influenza-like disease and negative influenza PCR results (ILD group; n = 252).
RESULTS: In the multivariable analysis lower C-reactive protein (CRP) level, lower white blood cell (WBC) count, fever, wheezing, cough, and the absence of nausea or sudden onset remained significant predictors of H1N1 influenza in adult patients (n = 263). Lower CRP level, lower WBC count, and cough remained significant predictors in pediatric patients (<16 years; n = 188).
CONCLUSION: Lower CRP level, lower WBC count, and cough were significant predictors of H1N1 in both the adult and pediatric patient group. These data may help to develop an improved case definition for suspected H1N1 infection which combines clinical findings and easily available laboratory parameters.

Entities:  

Mesh:

Year:  2013        PMID: 24190398     DOI: 10.1007/s15010-013-0549-1

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  24 in total

1.  Infectious disease. Antiviral agents for the treatment and chemoprophylaxis of influenza.

Authors: 
Journal:  Ann Emerg Med       Date:  2011-09       Impact factor: 5.721

2.  Difference between early clinical features of swine origin A H1N1 influenza confirmed and not confirmed infection in Mexico.

Authors:  Monica Rodríguez-Valero; Hector Manuel Prado Calleros; Gerardo Arturo Bravo Escobar; Rafael Ricardo Valdez Vázquez; Rafael Figueroa Moreno; Guillermo Martínez Montes; Simón Kawa Karasik
Journal:  J Infect Dev Ctries       Date:  2012-04-13       Impact factor: 0.968

3.  Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.

Authors:  Bin Cao; Xing-Wang Li; Yu Mao; Jian Wang; Hong-Zhou Lu; Yu-Sheng Chen; Zong-An Liang; Lirong Liang; Su-Juan Zhang; Bin Zhang; Li Gu; Lian-He Lu; Da-Yan Wang; Chen Wang
Journal:  N Engl J Med       Date:  2009-12-09       Impact factor: 91.245

4.  2009 pandemic influenza A (H1N1): clinical and laboratory characteristics in pediatric and adult patients and in patients with pulmonary involvement.

Authors:  Ing-Kit Lee; Jien-Wei Liu; Lin Wang; Kuender D Yang; Chung-Chen Li; Hock-Liew Eng
Journal:  Influenza Other Respir Viruses       Date:  2012-07-30       Impact factor: 4.380

5.  Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

Authors:  Anand Kumar; Ryan Zarychanski; Ruxandra Pinto; Deborah J Cook; John Marshall; Jacques Lacroix; Tom Stelfox; Sean Bagshaw; Karen Choong; Francois Lamontagne; Alexis F Turgeon; Stephen Lapinsky; Stéphane P Ahern; Orla Smith; Faisal Siddiqui; Philippe Jouvet; Kosar Khwaja; Lauralyn McIntyre; Kusum Menon; Jamie Hutchison; David Hornstein; Ari Joffe; Francois Lauzier; Jeffrey Singh; Tim Karachi; Kim Wiebe; Kendiss Olafson; Clare Ramsey; Sat Sharma; Peter Dodek; Maureen Meade; Richard Hall; Robert A Fowler
Journal:  JAMA       Date:  2009-10-12       Impact factor: 56.272

6.  Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.

Authors:  Seema Jain; Laurie Kamimoto; Anna M Bramley; Ann M Schmitz; Stephen R Benoit; Janice Louie; David E Sugerman; Jean K Druckenmiller; Kathleen A Ritger; Rashmi Chugh; Supriya Jasuja; Meredith Deutscher; Sanny Chen; John D Walker; Jeffrey S Duchin; Susan Lett; Susan Soliva; Eden V Wells; David Swerdlow; Timothy M Uyeki; Anthony E Fiore; Sonja J Olsen; Alicia M Fry; Carolyn B Bridges; Lyn Finelli
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

7.  Severe 2009 H1N1 influenza in pregnant and postpartum women in California.

Authors:  Janice K Louie; Meileen Acosta; Denise J Jamieson; Margaret A Honein
Journal:  N Engl J Med       Date:  2009-12-23       Impact factor: 91.245

8.  Distinguishing characteristics between pandemic 2009-2010 influenza A (H1N1) and other viruses in patients hospitalized with respiratory illness.

Authors:  Philip A Chan; Leonard A Mermel; Sarah B Andrea; Russell McCulloh; John P Mills; Ignacio Echenique; Emily Leveen; Natasha Rybak; Cheston Cunha; Jason T Machan; Terrance T Healey; Kimberle C Chapin
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

9.  Performance of the QuickVue Influenza A+B rapid test for pandemic H1N1 (2009) virus infection in adults.

Authors:  Wolfgang Poeppl; Harald Herkner; Heinz Burgmann; Tom Pustelnik; Gerhard Mooseder; Theresia Popow-Kraupp; Monika Redlberger-Fritz
Journal:  PLoS One       Date:  2011-12-01       Impact factor: 3.240

10.  Comparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children.

Authors:  Cees C van den Wijngaard; Liselotte van Asten; Marion P G Koopmans; Wilfrid van Pelt; Nico J D Nagelkerke; Cornelia C H Wielders; Alies van Lier; Wim van der Hoek; Adam Meijer; Gé A Donker; Frederika Dijkstra; Carel Harmsen; Marianne A B van der Sande; Mirjam Kretzschmar
Journal:  PLoS One       Date:  2012-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.